ACG announces plans to grow its Latin American presence with its newest capsule production plant in Brazil, as it continues to expand its facilities in Asia-Pacific and Europe.
Quintiles on Thursday announced the selection of Hospital Italiano of Buenos Aires, Argentina, as the company’s first “Prime Site” in Latin America, adding to the company’s network of investigative sites worldwide.
Fresh off the near completion of its depot in Sau Paulo, Brazil, Marken has now also completed the construction of another depot in Santiago, Chile, in order to more easily handle the influx of clinical trial specimens coming from South America.
Full-service CRO JSS Medical Research is extending its presence in Latin America permanently with the acquisition of LatAm Clinical Trials, a multinational CRO based in South and Central America.
CTI has teamed with Akron Clinical to form a Latin America joint venture with local knowledge and established relationships with North American and European pharma companies.
Synthon has completed the acquisition of Mexico-based Nafar Laboratories, adding to its presence in Latin America which includes recent purchases in Chile and Argentina.
Drug development partnering site goBalto’s addition of Latin American clinical sites to its database in a deal with Chilean CRO Clinical Trials Support (CTS) is timely given the pharma and biotech industry’s focus on emerging markets.
Automation expenditures in pharma manufacturing are predicted to reach $3bn (€2.15bn) by 2012 because companies must invest in the current “adapt or die” environment, according to a report.
Despite going through a difficult period PharmaNet is continuing to expand through the opening of another office in Latin America, which reinforces its commitment to the region.
The FDA has established its first permanent presence in Latin America by opening an office in Costa Rica as part of “Beyond Our Borders Initiative”, which has also seen the agency set up three sites in China.
in-PharmaTechnologist.com presents its round up of the latest developments in contract research, including CTI partnering to access Latin America, Encorium signing contracts worth $13.5m and Omnicare setting up in Sweden.
Patheon gave an update on its restructuring plans in Puerto Rico
yesterday, saying that its plant in Manati will be updated to
provide contract manufacturing of high-potency drugs and controlled
substances.
Despite all the hype over clinical trial offshoring, the US still
dwarfs the scene, with emerging countries as yet only a blip on the
radar, a unique new study reveals.
inVentiv Clinical has become the latest contract research
organisation (CRO) to open up shop in blossoming Latin America in a
bid to gain more of a global reach.
i3 has announced new plans to expand its pharmaceutical services
offerings across four continents - India, Latin America, and
Eastern and Western Europe.
ReSearch Pharmaceutical Services (RPS), a US based outsourcing
company, has announced expansion plans in Latin America. This
reflects the increasing trend of pharmaceutical companies
exploiting the cost benefits associated with outsourcing...
Parexel has expanded its regulatory and clinical development
services in the booming Latin American region, recently opening a
new location in Mexico City.
Kendle, who has been expanding its reach across the globe,
targeting the emerging Asia Pacific and Latin American markets, has
announced the acquisition of Latin American-based contract research
organisation, International Clinical...
Contract Research Organisation (CRO) Averion, and the SIPLAS
Research Organisation has signed an agreement to provide promotion
and support of clinical trials in a move that that reinforces Latin
America as an emerging hub of clinical...
Latin America shows considerable and untapped business potential
for the pharmaceutical industry, according to new research
conducted by PricewaterhouseCoopers.
